精華

-1.10 (-1.12%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

97.1077成交張數12.09本益比0.76股價淨值比5.97%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	77	64	17.0%	3.47	127.15	6.4%	5.1%	2.6	2.5
2026Q1	76	63	16.9%	3.53	125.54	5.6%	4.5%	-1.3	-1.4
2025Q4	78	66	16.1%	3.87	129.94	6.9%	5.7%	3.9	3.7
2025Q3	76	64	15.1%	4.12	127.25	8.9%	7.4%	0.6	0.4
2025Q2	80	63	21.4%	2.89	124.58	10.1%	7.9%	0.3	0.1
2025Q1	81	63	22.6%	2.77	124.03	11.9%	9.2%	1.1	0.9
2024Q4	81	66	19.1%	3.43	130.07	11.8%	9.4%	4.6	4.5
2024Q3	77	63	17.7%	3.68	125.05	10.2%	8.2%	1.7	1.5
2024Q2	79	61	22.6%	2.83	121.15	9.5%	7.1%	1.9	1.5
2024Q1	78	60	23.1%	2.74	118.48	9.8%	7.2%	1.4	1.1
2023Q4	78	61	20.9%	3.07	121.71	8.8%	6.8%	3.5	3.3
2023Q3	76	60	20.5%	3.16	119.54	10.2%	8.0%	3.2	2.8
2023Q2	81	59	27.5%	2.32	116.81	13.4%	9.4%	3.5	3.0
2023Q1	81	58	29.2%	2.17	114.09	15.7%	10.7%	-0.5	-0.9
2022Q4	83	63	24.5%	2.78	124.32	16.7%	12.1%	3.4	2.9
2022Q3	79	61	23.3%	2.90	120.37	18.1%	13.2%	3.9	3.7
2022Q2	85	58	32.2%	2.02	114.24	17.7%	12.6%	2.5	2.2
2022Q1	84	55	34.5%	1.85	109.40	17.9%	12.4%	3.1	2.7
2021Q4	86	60	30.6%	2.18	118.44	16.3%	11.4%	4.7	4.5
2021Q3	82	57	30.2%	2.21	113.83	17.1%	11.8%	5.5	5.2
2021Q2	82	61	25.8%	2.81	120.22	14.0%	9.5%	1.9	1.8
2021Q1	80	59	27.1%	2.64	116.08	12.1%	8.8%	0.3	0.1
2020Q4	80	56	30.1%	2.31	111.59	13.1%	9.0%	4.3	4.1
2020Q3	79	54	32.4%	2.08	106.46	15.3%	10.1%	2.0	1.9
2020Q2	84	52	37.5%	1.78	104.10	18.9%	11.1%	2.3	2.2
2020Q1	84	60	28.2%	2.75	119.33	18.9%	13.2%	-0.1	-0.2
2019Q4	84	58	31.5%	2.33	114.32	22.3%	15.0%	1.4	1.2
2019Q3	85	54	35.8%	1.96	108.04	25.8%	16.6%	6.6	6.5
2019Q2	93	52	44.3%	1.55	102.55	30.3%	16.5%	3.9	2.9
2019Q1	91	62	31.9%	2.48	122.84	28.5%	19.2%	1.8	0.3
2018Q4	87	58	33.6%	2.16	115.16	29.8%	19.2%	6.4	5.9
2018Q3	84	54	35.6%	1.97	106.75	31.6%	20.3%	4.6	2.8
2018Q2	93	50	46.8%	1.49	98.48	36.4%	19.8%	5.8	3.8
2018Q1	87	57	33.7%	2.39	113.92	30.4%	21.3%	-0.0	-0.4
2017Q4	86	54	37.3%	2.13	106.94	30.1%	19.9%	8.1	2.7
2017Q3	78	50	36.2%	2.43	99.26	34.6%	23.3%	3.4	-6.6
2017Q2	81	45	44.3%	1.70	89.41	37.1%	21.1%	5.7	5.2
2017Q1	73	54	25.8%	3.52	107.40	31.0%	22.9%	0.4	0.4
2016Q4	73	52	29.5%	2.99	102.69	–	–	9.4	9.3
2016Q3	66	47	28.7%	3.04	93.19	–	–	5.7	5.6